Skip to main content
VCbacked
Log inGet Started

Lytos Technologies, Inc.

Charlottesville, United States

Lytos is a biotech platform company tackling AMR with technologies that disrupt biofilms, kill pathogens, and replace traditional chemicals.

$6.3M raised
Jan 2025
Seed
Biotechnology

Top Investors

Shenandoah Valley Founders GroupCAV Angels

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lytos Technologies, Inc.

How much funding has Lytos Technologies, Inc. raised?
Lytos Technologies, Inc. has raised $6.3M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Who are Lytos Technologies, Inc.'s investors?
Lytos Technologies, Inc.'s investors include Shenandoah Valley Founders Group, CAV Angels.
Where is Lytos Technologies, Inc. headquartered?
Lytos Technologies, Inc. is headquartered in Charlottesville, United States.
What does Lytos Technologies, Inc. do?
Lytos is a biotech platform company tackling AMR with technologies that disrupt biofilms, kill pathogens, and replace traditional chemicals.
What stage is Lytos Technologies, Inc. at?
Lytos Technologies, Inc. is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lytos Technologies, Inc. — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/lytos-technologies-inc. Accessed July 2, 2026.
APA
VCBacked. (2025). Lytos Technologies, Inc. — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lytos-technologies-inc
Wikipedia (cite web)
{{cite web |title=Lytos Technologies, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/lytos-technologies-inc |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K